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EXECUTIVE SUMMARY 
x In recent years, there has been increasing concern over the environmental risks of the so 
FDOOHG µHPHUJLQJ FRQWDPLQDQWV¶ (&V (&V RULJLQDWH IURP D YDULHW\ RI SURGXFW W\SHV
including human pharmaceuticals, veterinary medicines, nanomaterials, personal care 
products, paints and coatings. Some ECs, such as natural products and transformation 
products of synthetic chemicals may be formed in the environment by biochemical processes 
in animals, plants and microbes. Environmental risk assessment schemes already exist in 
certain regions for these substances. 
x ECs are not necessarily new chemicals; they may be substances that have been present in the 
environment for a long time but whose presence and significance are only now being 
recognised. Data for ECs are often scarce and methods for detection in the natural 
environment may be non-existent or at an early stage of development. For some classes of 
ECs, existing environmental assessment methods (e.g. exposure models and fate and effects 
test approaches), may not be appropriate.  
x ECs will be released to the agricultural environment via a number of routes. They may be 
released directly to the environment (e.g. veterinary medicines that are used to treat animals 
at pasture). They may also enter the environment indirectly during the application of manure, 
biosolids or other solid waste materials to soil. Once in soil ECs may be transported to water 
bodies by leaching, runoff and drainage processes. The extent of the transport is dependent 
on the persistence of the EC and on how it interacts with soil and sediment particles. 
x ECs will also be released to the aquatic environment from non-agricultural sources 
(e.g. emissions from wastewater treatment plants). For some classes of ECs (e.g. human 
medicines and human personal care products), emissions from these other sources are likely 
to be more significant than emissions from agriculture. For veterinary medicines, hormones, 
selected transformation products and natural toxins, agriculture is the most significant source 
of water contamination.  
x Many ECs appear to behave differently in environmental systems than other agricultural 
contaminants (such as traditional pesticide active ingredients and persistent organic 
pollutants). This means that modelling approaches that have been developed for predicting 
fate properties and exposure of other contaminants are not always appropriate for ECs. 
x Detection of ECs in environmental media can be challenging. However, robust methods are 
now available for many ECs, including selected human and veterinary medicines, personal 
care products, and transformation products of synthetic chemicals. Methods are currently 
poorly developed for the detection and characterisation of engineered nanoparticles in soils 
and natural waters. 
x While a large number of studies have investigated the occurrence of a wide range of ECs 
across the globe, only a few studies have specifically investigated occurrence of ECs in 
agricultural systems. The studies that have looked at agricultural systems have detected a 
range of ECs including veterinary drugs, human pharmaceuticals, personal care products, 
hormones and transformation products of man-made chemicals. Generally, reported 
concentrations are very low (i.e. in the ng/l range). 
8 
 
x Most ECs cause acute toxicity at high concentrations. These concentrations are typically 
much higher than concentrations measured in the environment indicating that ECs are 
unlikely to cause acute effects on organisms in the systems where the monitoring has been 
done. 
x A range of non-standard effects have been reported for different ECs, in particular for ECs 
that are designed to be biologically active (e.g. veterinary and human medicines). These 
effects are often seen at concentration levels close to those measured in the environment. 
However, the implications of these effects in terms of ecosystem functioning have yet to be 
established. 
x The environment will be exposed to a mixture of ECs and other contaminants. The impact of 
these mixtures is likely to be greater than the impact of the single substances on their own. It 
is therefore important that we begin to consider the potential implications of these mixture 
interactions in terms of risk. This is a general problem that is also relevant to non emerging 
contaminants such as pesticides, persistent organic pollutants and heavy metals. 
x New ECs are likely to emerge in the future due to technological developments and changes 
in demographics, society, land-use and climate. It is important that we begin to develop 
µKRUL]RQ-scanninJ¶ approaches to anticipate these changes. 
x It is important that we work to identify ECs of most concern so that resources can be focused 
on the bigger problems. A number of prioritisation approaches already exist for horizon 
scanning for different classes of ECs. However, these approaches need further development 
and need to be applied more widely. In order to co-ordinate resources, it may be appropriate 
WR HVWDEOLVK DQ LQWHUQDWLRQDO ZDWFKGRJ RQ (&¶V RU WR SURPRWH JUHDWHU LQWHUQDWLRQDO
cooperation. 
9 
 
NEW AND EMERGING WATER POLLUTANTS ARISING FROM AGRICULTURE 
by 
 
Alistair B.A. Boxall1 
1. Introduction 
Until very recently, the main focus on the impacts that chemicals cause in the environment has 
been on nutrients heavy metals, µWUDGLWLRQDO¶ DFWLYH LQJUHGLHQWV LQ pesticide products and persistent 
organic pollutants. However, in recent years, there has been increasing concern over the environmental 
ULVNVRIWKHVRFDOOHGµHPHUJLQJFRQWDPLQDQWV¶ (&V(&s originate from a variety of product types 
including human pharmaceuticals, veterinary medicines, nanomaterials, personal care products, paints 
and coatings. Some ECs, such as the natural toxins and degradation products of man-made chemicals 
may also be formed within the natural environment by animals, plants and microbes. The increasing 
concern over the risks of ECs is reflected by a rapid increase in the numbers of scientific publications 
exploring the environmental impacts of ECs over the past decade (Figure 1) and the appearance of 
numerous articles in the popular press across the world. 
)LJXUH1XPEHUVRISXEOLFDWLRQVZLWKWKHZRUGVµHPHUJLQJFRQWDPLQDQWV¶DQGµHQYLURQPHQW¶LQWKHWLWOH
or abstract published since 2003 
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Source: Taken from Web of Science. 
                                                     
1. EcoChemistry Research Group, Environment Department, University of York, Heslington, York, 
United Kingdom. 
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Numerous classes of ECs have been shown to be released to the environment, or in the case of 
nanomaterials, will be released to the environment in increasing amounts in the future. In the 
environmental monitoring studies that have looked for them, (&¶V have been detected in a range of 
environmental compartments including surface waters, groundwaters, drinking waters, fish and 
earthworms across the globe (e.g. Kolpin et al., 2002, Juhler et al., 2001; Ferrer et al., 2000; Kolpin et 
al., 1998a and b; Schnoebelen et al., 2001; Battaglin et al., 2003; Li et al., 2002; Zimmerman et al., 
2002; Lagana et al., 2002).   
Alongside the monitoring, studies have been performed to explore the effects of a range of ECs 
on the biochemistry, cell structure, growth, reproduction and mortality of organisms in the 
environment and on populations and communities in surface water and soil systems. While much of 
the data that has been produced on different classes of ECs indicates that many pose a small risk to 
ecosystems and human health there is some evidence that selected emerging contaminants could affect 
human and environmental health. For example, the veterinary use of diclofenac, which is a human 
pharmaceutical used as an anti-inflammatory treatment, was found to be responsible for the massive 
decline in populations of vulture species in certain areas of Asia (Oaks et al., 2004); the veterinary 
drug ivermectin, which is used to treat parasitic infections in livestock, has been shown to affect the 
growth of  aquatic invertebrates at concentration lower than those that are expected to occur in the 
aquatic environment (Garric et al., 2007); ethinylestradiol, one of the active ingredients in the 
contraceptive pill, has been associated with endocrine disruption in fish (Lange et al., 2001); and there 
is concern that long-term exposure to antibiotic pharmaceuticals, used in human and veterinary 
medicine, may be contributing to the selection of resistant bacteria in the environment which may have 
significant implications for human health (Boxall et al., 2003a).  
This paper provides an overview of those ECs that have an agricultural-based origin or which 
may be released to agricultural systems, which may be of concern to water quality. The first section 
defines what an EC is. Subsequent sections then discuss the potential inputs, fate and transport, effects 
and risks of ECs in agricultural systems. An overview of existing regulatory systems that cover ECs is 
provided and possible prioritization approaches for identifying those ECs that are likely to pose the 
greatest risk to human health and the environment are discussed. Finally, recommendations on future 
research priorities are given. 
2. What is an emerging contaminant? 
ECs are not necessarily new chemicals; they may be substances that have been present in the 
environment for a long time but whose presence and significance are only now being recognised. Data 
for ECs are often scarce and methods for detection in the natural environment may be non-existent or 
at an early stage of development. There is no internationally agreed definition for an emerging 
contaminant and a number of definitions have been proposed (Box 1). Many of these definitions are 
contradictory and could apply to many of the environmental contaminants that we have been studying 
for many years.  
,ZRXOGDGYRFDWHWKDWDQµHPHUJLQJFRQWDPLQDQW¶LVµDFRQWDPLQDQWIURPDFKHPLFDOFODVVWKDWVR
far has not been studied extensively, where there is either a concern from stakeholders (scientists, 
regulators, NGOs etc.), that the contaminant class may be having an impact on environmental or 
human health; or where there is a concern that existing environmental assessment paradigms are not 
DSSURSULDWHIRUWKHFRQWDPLQDQWFODVV¶ 
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Box 4.  'HILQLWLRQVRIµHPHUJLQJFRQWDPLQDQWV¶LQGLIIHUHQWUHJLRQVVHFWRUV 
"Substances that have been detected in the environment, but which are currently not included in routine 
monitoring programmes at EU level and whose fate, behaviour and (eco)toxicological effects are not ZHOOXQGHUVWRRG´
(definition of the EU NORMAN network) 
³7KRVHFKHPLFDOV WKDW UHFHQWO\KDYHEHHQVKRZQ WRRFFXUZLGHO\ LQZDWHU UHVRXUFHVDQG LGHQWLILHGDVEHLQJD
potential environmental or public health risk, and yet adequate data do not exist to determiQHWKHLUULVN´GHILQLWLRQRI
the Consortium for Research and Education on Emerging Contaminants)  
³+D]DUGRXV PDWHULDOV FKHPLFDO PLFURELDO RU UDGLRORJLFDO VXEVWDQFHV RU PL[WXUHV RI LQWHUHVW WKDW DUH
characterized by: a perceived or real threat to human health, public safety or environment; no currently published 
health standard/guideline exists or it is evolving or being re-evaluated; there is insufficient or limited available 
toxicological information; or, a new source, pathway, or detection limit has been discovered. Emerging contaminants 
PD\EHQDWXUDOO\RFFXUULQJRUPDQPDGH´GHILQLWLRQRIWKH6WDWHRI0DVVDFKXVHWWV 
³&RQWDPLQDQWVZLWKDSRWHQWLDOWKUHDWWRKHDOWKDQGHQYLURQPHQWWKDWKDYHQRUHJXODWRU\VWDQGDUG´GHILQLWLRQRI
the State of South Carolina) 
³$FKHPLFDORUPDWHULDOWKDWKDVSDWKZD\VWRHQWHUWKHHQYLURQPHQWDQGSUHVHQWVSRWHQWLDOXQDFFHSWDEOHKXPDQ
health or environmental risks, and either does not have regulatory peer-reviewed human health standards or the 
regulatory standards are evROYLQJ GXH WR VFLHQFH GHWHFWLRQ FDSDELOLWLHV RU QHZ SDWKZD\V´ GHILQLWLRQ RI &KHPLFDO
Material Risk Management) 
³$Q\ V\QWKHWLF RU QDWXUDOO\ RFFXUULQJ FKHPLFDO RU DQ\ PLFURRUJDQLVP WKDW LV QRW FRPPRQO\ PRQLWRUHG LQ WKH
environment but has the potential to enter the environment and cause known or suspected adverse ecological and/or 
human health effects. In some cases, release of emerging chemical or microbial contaminants to the environment has 
likely occurred for a long time, but may not have been recognized until new detection methods were developed. In 
other cases, synthesis of new chemicals or changes in use and disposal of existing chemicals can create new sources 
RIHPHUJLQJFRQWDPLQDQWV´GHILQLWLRQRIWKH86*HRORJLFDO6XUYH\ 
ECs arise from a plethora of product types and cover a wide range of chemical classes. In terms 
of agricultural systems, there are a number of EC types of potential concern, including: 
x Naturally produced compounds such a toxins produced by fungi, bacteria and plants; 
x Bio-terrorism/sabotage agents;  
x Human personal care products such as essential oils, herbal medicines, antibacterials and 
fragrances; 
x Emerging persistent organic pollutants such as flame retardants and dioxin-like compounds; 
x Veterinary medicines such as antibiotics and antiparasitic agents; 
x Hormones such as synthetic and natural estrogens and androgens; 
x Nanomaterials;  
x Human medicines;  
x Metabolites and transformation products of man-made chemicals that are produced from 
biological, chemical and physical breakdown reactions. 
A detailed list of EC classes along with example substances is available on the EU NORMAN network 
website (www.norman-network.net). 
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3. Sources of emerging contaminants into the agricultural environment 
ECs will be released to the agricultural environment via a number of routes (Figure 2). Veterinary 
medicines and their metabolites will be released directly to soils (animals at pasture) or indirectly 
when manure and slurry from intensive livestock facilities is applied to agricultural land as a fertiliser 
(Boxall et al., 2004a). Human pharmaceuticals and personal care products will be released through the 
application of sewage sludge (biosolids) to land or from irrigation with wastewater effluent. Other ECs 
may be formed in the environment itself. Detailed examples are provided below. 
Figure 2. Routes of entry of ECs to the agricultural environment 
Human use 
Pharmaceuticals 
Personal care products 
Nanomaterials 
Flame retardants 
Metabolites 
 
Plant protection 
Nanomaterials 
Livestock use 
Hormones 
Veterinary medicines 
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Waste or 
Wastewater 
treatment 
 
 
Manure 
storage 
  
 Formation       Formation of 
 of transformation        Agricultural soils    natural toxins 
 products          
 
Excretion to 
soils 
Application 
Manure 
application 
Excretion to 
soils 
Sludge/biosolid 
Application ; wastewater 
Irrigation; compost 
application etc. 
 
Source: Author. 
New ECs may also be added intentionally to agricultural systems in the future. For example, it is 
likely that pesticides may increasingly be applied in the nano-scale (i.e. as particles in the size range 1-
100 nm; Lyons and Scrinis, 2009). Existing pesticides may by made in the nanoparticulate form to 
give the active ingredient beneficial properties for pest control, such as increased solubility, increased 
stability, the capacity for absorption into plants or increased toxicity to pests (Lyons and Scrinis, 
2009). Pesticides may also be nano-encapsulated to create nano-scale capsules, which can be designed, 
for example, to release the pesticide in specific environments, such as inside the stomach of an insect. 
7KHVH µVPDUW¶SHVWLFLGHVFRXOGSURYLGHPRUHSUHFLse, controlled and effective use of pesticides, and 
therefore potentially reduce the overall quantities of pesticide used (Lyons and Scrinis, 2009).  
ECs may also be created in the agricultural environment itself. Many man-made substances that 
enter agricultural systems will be degraded by chemical, physical and biological processes. While 
these reactions may result in the complete breakdown of a chemical (i.e. they convert the chemical to 
carbon dioxide, water and methane), in many instances the processes may result in the formation of 
stable intermediate chemicals which we call degradation or transformation products (e.g. Roberts, 
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1998, Roberts and Hutson, 1999). Many ECs are also produced naturally by fungi, bacteria, algae, 
plants, and animals. According to their origin, these toxins are usually separated into the categories: 
mycotoxins (fungal origin), bacterial toxins (bacterial origin), phycotoxins (algal origin), phytotoxins 
(plant origin), and zootoxins (animal origin) (van Egmond, 2004). These are usually produced by the 
organisms as a defence mechanism. 
While human pharmaceuticals, personal care products and other ECs originating from 
households, towns and cities are not applied directly to agricultural systems, they are able to enter the 
agricultural environment indirectly. Following use, many of these ECs will be released to the 
wastewater system. Typical wastewater systems involve a primary treatment phase, where solid 
material is settled out and removed, followed by a secondary treatment where microbes are used to 
breakdown organic matter (including chemicals). One common secondary treatment process is 
activated sludge treatment (AS). In AS, chemical contaminants may be degraded but can also stick to 
the sludge particles in the system. At the end of the process, the sludge is removed and, as it is high in 
nutrients, in many regions is then applied to agricultural land as a fertiliser. ECs that stick to sludge 
can therefore enter the environment when sludge (biosolids) from wastewater treatment works is 
applied to land (Kinney et al., 2006; Topp et al., 2008a).  
4. The significance of agriculture as a source of ECs 
As discussed above, ECs originate from a wide range of sources and, in some instances, inputs to 
surface waters from agricultural activities may be insignificant compared to other sources. For 
example, agricultural inputs of ECs from human medicines and personal care products into the aquatic 
environment are probably less important than other routes of entry into the natural environment. These 
products are typically used by society all the time and therefore emitted continuously from wastewater 
treatment systems into the aquatic environment whereas sludge application to land will tend to happen 
only at certain times of year. Therefore, pharmaceuticals and personal care products are likely to occur 
sporadically in agricultural waterbodies. The actual concentrations of pharmaceuticals and personal 
care products transported from agricultural soils to surface waters are also much lower than seen in 
sewage effluent (Topp et al., 2008). 
The ECs where agriculture is currently the predominant source of surface water contamination, 
compared to non-agricultural sources, are the natural toxins, veterinary medicines, hormones and 
transformation products of man-made chemicals used in agriculture. For some ECs, agriculture might 
be an important source of contamination in the future. For example, if pesticides are developed in the 
nano-form in the future, it is likely that these materials will be transported to and contaminate surface 
waters. For some ECs, e.g. bioterrorism/sabotage agents, the importance of agriculture as a source of 
contamination is difficult to predict. 
The potential routes of input of different classes of ECs to surface waters are summarised in 
Table 1. The table also provides an indication of the relative importance of agricultural releases 
compared to other sources. It is important to recognise that the relative importance of the different 
source may vary according to regional differences in e.g. farming and wastewater treatment practices 
and to differences in the physical and chemical properties of individual ECs within a class. 
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Table 1. Routes of input of ECs to surface waters and the importance of agricultural inputs compared to 
other sources 
Emerging contaminant 
class 
Route of input to 
agricultural systems 
Other sources to the 
environment 
Relative importance of 
agricultural sources in 
terms of water 
contamination 
Natural toxins Release from plants, 
algae and fungi 
NA High 
Veterinary medicine Direct release to soils 
from animals at pasture; 
application of 
contaminated manure and 
slurry to land 
Use in aquaculture; 
manufacturing releases; 
disposal of containers 
High 
Hormones Direct release of natural 
and synthetic hormones 
by animals at pasture; 
application of manure and 
slurry to land 
Application of sewage 
sludge, containing natural 
and synthetic hormones 
arising from the human 
population 
High ± hormonal 
substances arising from 
animals 
Low ± hormonal 
substances arising from 
the human population 
Transformation products Produced from man 
made chemicals that are 
applied directly to 
agricultural systems or in 
activated sludge/irrigation 
water 
Formed in wastewater 
treatment processes 
Dependent on the nature 
of the parent compound: 
High (TPs of veterinary 
medicines) 
Low (TPs of 
pharmaceuticals, 
personal care products 
etc.) 
Nanomaterials Application of 
nanopesticides to crops; 
release of nanomedicines 
by livestock; application of 
sewage sludge to 
agricultural land as a 
fertiliser; irrigation with 
wastewater or 
contaminated surface 
water 
Emissions from 
wastewater treatment 
plants; disposal of waste 
to landfill; manufacturing 
releases 
Currently low as 
nanomaterials are mainly 
used in personal care 
products and paints and 
coatings 
Importance could 
increase in the future as 
the nanopesticide and 
nanomedicine markets 
develop.  
Bioterrorism/sabotage 
agents 
Sabotage of crops and 
livestock 
Chemical incidents in 
cities 
Has the potential to be 
high (depending on the 
agent) 
Human personal care 
products 
Application of sewage 
sludge to agricultural land 
as a fertiliser; irrigation 
with wastewater or 
contaminated surface 
water 
Emissions to surface 
waters from wastewater 
treatment plants 
Low 
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Table 1. (continued) Routes of input of ECs to surface waters and the importance of agricultural 
inputs compared to other sources 
Emerging contaminant 
class 
Route of input to 
agricultural systems 
Other sources to the 
environment 
Relative importance of 
agricultural sources in 
terms of water 
contamination 
Emerging persistent 
organic pollutants 
(e.g. flame retardants) 
Application of sewage 
sludge to agricultural land 
as a fertiliser; irrigation 
with wastewater or 
contaminated surface 
water 
Emissions to surface 
waters from wastewater 
treatment plants 
Low 
Human medicines Application of sewage 
sludge to agricultural land 
as a fertiliser; irrigation 
with wastewater or 
contaminated surface 
water 
Emissions from 
wastewater treatment 
plants; disposal of unused 
medicines to landfill; 
manufacturing releases 
Low 
5. Fate and transport of ECs in agricultural systems 
Once an EC is released to or formed in the agricultural environment, it will experience the same 
fate and transport processes that occur for other classes of agricultural contaminant (Figure 3). The EC 
may be degraded by biological, physical or chemical processes, it may stick to soil particles, it may be 
taken up by plants, it may leach to groundwater or it may be transported to surface waters through 
runoff and drainage water. The extent to which any of these processes happens will depend on the 
underlying physical properties of the EC (including how soluble it is in water solubility; how attracted 
the EC is to organic matter and other soil components; and how volatile the substance is) as well as the 
properties of the soil and the climatic conditions. In the following sections information on the fate and 
transport of emerging contaminants in the environment is reviewed. 
Figure 3. Fate and transport processes for contaminants in the agricultural soil environment 
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5.1 Sorption in soil 
When applied to a field, chemicals may associate with soil particles by attaching to the surface of 
the soil and/or moving inside the soil particle. This process is known as sorption and is a very 
important factor in determining whether a chemical is going to move to surface waters and 
groundwaters or not, it also affects the degradation of a chemical. For pesticides and the persistent 
organic pollutants, our understanding of sorption behaviour in soils is well developed due to 
significant research over the years. These contaminants typically interact with the organic carbon in 
the soil and sorption behaviour can be predicted from a knowledge of the hydrophobicity (which is a 
measure of the attractiveness of the contaminant to organic material) of the chemical. Equations exist 
for estimating the sorption behaviour of a chemical in soils based on the hydrophobicity of the 
chemical and the total organic carbon content of the soil and these are routinely used in environmental 
exposure modelling and environmental risk assessment. While, these equations are probably valid for 
many ECs, many other ECs, including the human and veterinary medicines and engineered 
nanomaterials, appear to behave differently. 
The sorption behaviour of human and veterinary medicines can vary vastly in different soil types 
and these differences in sorption of a given compound in different soils cannot be explained by 
variations in soil organic carbon but are explained by the fact that many pharmaceuticals are polar 
meaning that they can exist in natural environments in both the unionized and ionized form (e.g. Ter 
Laak et al., 2006a and b). As a result, the chemicals do not just interact with the organic carbon in the 
soil but also with other soil components such as metal oxides and clay particles (Ter Laak et al., 
2006b) and the sorption behaviour is very dependent on properties of the soil, such as soil pH. The 
complexities of these interactions means that modelling approaches, developed for predicting the 
sorption of other groups of chemicals (e.g. pesticides and neutral organics), are inappropriate for use 
on many human and veterinary medicines. Great care should therefore be taken when using existing 
PRGHOOLQJDQGULVNDVVHVVPHQWDSSURDFKHVGHYHORSHGIRUµWUDGLWLRQDO¶FKHPLFDOFODVVHVWR(&V 
Many ECs will also enter the agricultural environment associated with manure and slurry and 
these matrices may also alter the behaviour and transport of ECs. Studies have demonstrated that the 
addition of manure or sludge can affect the sorption behaviour of veterinary and human medicines and 
personal care products and that they may also affect persistence (e.g. Boxall et al., 2002; Thiele Bruhn 
and Aust, 2004; Monteiro and Boxall., 2009; Topp et al., 2008b; Al Rajab et al., 2009). In some cases, 
the addition of the sludge or manure increases sorption and persistence and in other cases, they 
decrease sorption and persistence. These effects have been attributed to changes in pH or alterations of 
the nature of dissolved organic carbon in the soil/manure system. 
Very few studies have explored the interaction of engineered nanoparticles with soil particles 
(e.g. Li et al., 2008). However, based on information for other processes, it is likely that the behaviour 
of these materials will be different from non-particulate contaminants and that new models and 
paradigms will need to be developed for engineered nanoparticles in the soil environment. 
5.2 Persistence in soil 
Like other contaminants, the main route for degradation of ECs in soils will be via aerobic (i.e. in 
an oxygen containing environment) biodegradation. Depending on the nature of the chemical, other 
degradation and depletion mechanisms may occur, including soil photolysis (caused by sunlight) and 
hydrolysis (caused by a reaction with water) (e.g. Wolters and Steffens, 2005). Most data on the 
persistence of ECs in soil are for veterinary and human medicines, personal care products and 
transformation products of pesticides and data on the persistence of these classes of ECs needs to be 
generated as part of the regulatory risk assessment processes for these products. 
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Like, sorption, the presence of the biosolid or sludge matrix seems to affect degradation rates 
compared to soil on its own. For example, for caffeine which not only arises from coffee consumption 
but also is used as a pharmaceutical, degradation rates in soils increased with addition of aerobically-
digested sewage sludge. In contrast, anaerobically-treated (i.e. treated in a low oxygen environment) 
sewage sludge did not accelerate caffeine mineralization (Topp et al., 2006). The degradation rate of 
the human pharmaceutical naproxen, an anti-inflammatory treatment, was also reported to be 
increased by the addition of activated sludge (Topp et al., 2008b).  
When assessing degradation in the laboratory, scientists typically look at the disappearance of the 
study compound using analytical extraction and detection techniques and also attempt to identify the 
transformation products and whether the compound is completely mineralized (i.e. degraded to carbon 
dioxide and water). In only a few published studies has the formation of degradation products of ECs 
been investigated (Kolz et al., 2005; Topp et al., 2008b). In these studies, no detectable transformation 
SURGXFWV ZHUH IRXQG IRU QDSUR[HQ RU WKH KRUPRQHV HVWURQH DQG ȕ-estradiol (Topp et al., 2008b). 
While some of the compounds are extensively mineralized, others are not yet the parent compound 
still disappears. One possible explanation for this is that the parent EC is binding very tightly to the 
soil particle and that this cannot be extracted by the analytical methods used in the degradation study. 
This phenomenon has also been observed for some pesticides and the fraction that cannot be extracted 
LVWHUPHGWKHµQRQ-H[WUDFWDEOHUHVLGXH¶1(57KHUHLVFXUUHQWO\FRQVLGHUDEOHGLVFXVVLRQSDUWLFXODUO\
in Europe, over how to deal with NERs in the environmental risk assessment process. Many people 
DUJXHWKDW1(5VFDQQRWEHLJQRUHGDVLWLVSRVVLEOHWKDWWKH\FRXOGEHµPRELOLVHG¶DWDODWHUGDWHGXHWR
changes in soil conditions. 
We know very little about the persistence of engineered nanomaterials in agricultural soils. 
Nanomaterials are likely to dissipate via different pathways than traditional chemicals. For example, 
the particles may aggregate or agglomerate which will alter the properties of the particle and some 
nanomaterials may undergo dissolution. Many nanomaterials are likely to be capped with organic 
molecules, it is possible that these cappings will be degraded by microbes or abiotic processes. To 
understand the behaviour of nanomaterials in agricultural systems, it is likely that we will need to 
begin to develop an understanding of all of these different pathways of dissipation. 
5.3 Transport in soil systems 
Contaminants applied to or formed in soil can be transported to aquatic systems in surface runoff, 
subsurface flow and drainflow. The extent of transport via any of these processes is determined by a 
range of factors, including: the solubility, sorption behaviour and persistence of the contaminant; the 
physical structure, pH, organic carbon content and cation exchange capacity of the soil matrix, and 
climatic conditions such as temperature and rainfall volume and intensity. Most work to date on 
contaminant transport from agricultural fields has focused on pesticides, nutrients and bacteria, but 
recently a number of studies have explored the fate and transport of ECs. Lysimeter (which is an intact 
and undisturbed soil column), field-plot and full-scale field studies have investigated the transport of 
veterinary medicines and pharmaceuticals and personal care products from the soil surface to field 
drains, ditches, streams, rivers and groundwater (e.g. Blackwell et al., 2007 and 2009; Kay et al., 
2004; 2005 a,b and c; Aga et al., 2003; Kreuzig and Holtge, 2005; Burkhard et al., 2005; Hamscher et 
al., 2005; Chefetz et al., 2008: Topp et al., 2008a; Lapen et al., 2008). A range of experimental 
designs and sampling methodologies has been used. These investigations are described in more detail 
below. 
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5.3.1 Leaching to groundwater 
A series of studies have explored the potential for ECs to leach from soils to groundwaters. These 
have involved laboratory column studies, lysimeter studies and full-scale field investigations. Oppel et 
al. (2004) used laboratory column studies to assess the potential for six pharmaceuticals to move from 
field surfaces to groundwaters. While the majority of the pharmaceuticals were found not to leach, two 
(clofibric acid and iopromide) were very mobile under the experimental conditions and thus, 
groundwater contamination would be possible if the soil is exposed to these pharmaceuticals, 
The movement of veterinary antibiotics from the sulfonamide and tetracycline groups, which are 
three of the most widely used classes of antibiotic in the world, in soil profiles has been investigated at 
the field scale using suction probes (Blackwell et al., 2007; Hamscher et al., 2000). In these studies, 
sulfonamide antibiotics were found at depth but the tetracyclines were not; most likely due to the high 
potential for tetracyclines to sorb to soil. Carlson and Mabury (2006) reported that chlortetracycline 
applied to agricultural soil in manure was detected at soil depths of 25 and 35 cm, but monensin, a 
coccidiostat, remained in the upper soil layers.   
There are only a few reports of veterinary medicines in groundwater (Hamscher et al., 2000; 
Hirsch et al., 1999). Residues of sulfonamide antibiotics were detected at a few of the study sites 
investigated by Hirsch et al. (1999) in Germany. Contamination at two of these sites was attributed to 
irrigation of agricultural land with domestic sewage but the other sites were believed to have become 
contaminated due to the application of animal manures to the soil surface (Hirsch et al., 1999).  
5.3.2 Runoff 
Transport of ECs via runoff (i.e. overland flow) has been observed for tetracycline antibiotics, 
sulfonamide antibiotics, anti-inflammatory agents, antiepileptic compounds, beta blockers, 
antidepressants, triclosan (an antibacterial compound used in toothpaste and chopping boards) and 
caffeine (Kay et al., 2005; Kreuzig et al., 2005b; Topp et al., 2008). Just like leaching, the transport of 
these substances is influenced by the sorption behaviour of the compounds, the presence of manure or 
sludge in the soil matrix and the nature of the land to which the manure or sludge is applied. Runoff of 
highly sorptive substances, such as tetracyclines, was observed to be significantly lower than the more 
mobile sulfonamides (Kay et al., 2005). However, even for the relatively water soluble sulfonamides, 
total mass losses to surface  are very small (with less than 0.6% of the mass applied being transported 
to surface waters) under actual field conditions (Stoob et al., 2007). Manure and slurry has been 
shown to increase the transport of sulfonamides via runoff by 10-40times in comparison to runoff 
following direct application of these medicines to soils (Burkhard et al., 2005). Possible explanations 
IRUWKLVREVHUYDWLRQLQFOXGHSK\VLFDO³VHDOLQJ´RIWKHVRLOVXUIDFHE\WKHVOXUU\DQGRUDFKDQJHLQS+
as a result of manure addition that alters the speciation and fate of the medicines (Burkhard et al., 
2005). It has been shown that overland transport from ploughed soils is significantly lower than runoff 
from grasslands (Kreuzig et al., 2005b). The application method can also influence the runoff 
behaviour of ECs, for example Topp et al., (2008) showed that application of sewage sludge by 
injection greatly reduced the runoff of a range of pharmaceuticals. The way in which the agricultural 
land is managed therefore seems to have a significant impact on the transport of ECs to surface waters 
and it is possible, that changes in land management practices could offer a management solution in the 
event that an EC is found to cause impacts in agricultural systems. 
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5.3.3 Drain flow 
The transport of a range of veterinary antibacterial substance (i.e. tetracyclines, macrolides, 
sulfonamides and trimethoprim (a veterinary drug that is often used in combination with sulfonamide 
antibiotics) has been investigated using lysimeter and field-based studies in tile-drained clay soils 
(Boxall et al., 2006; Kay et al., 2004). Following application of pig slurry spiked with oxytetracycline 
and sulfachloropyridazine, the test compounds were detected in drainflow water (Kay et al., 2004). 
Concentrations of the sulfonamide were an order of magnitude higher than the tetracycline even 
though the amount of each test compound applied to the field was similar, these difference are again 
likely due to differences in sorption behaviour. In a subsequent investigation at the same site (Kay et 
al., 2004), in which the soil was tilled, much lower concentrations were observed in the drainflow 
suggested that tillage may be a useful mitigation strategy in the even that a veterinary product is found 
to pose a risk to aquatic systems. While the pig slurry used in these studies was obtained from a pig 
farm where tylosin was used as a prophylactic treatment, this substance was not detected in any 
drainflow samples; possibly because it is not persistent in slurry (Loke et al., 2000).  
Similar studies have been done on human pharmaceuticals in tile drain water from sludge-
amended fields (Lapen et al., 2008 and 2009). A range of pharmaceuticals and personal care products 
were observed in the drainage waters including naproxen, acetaminophen, ibuprofen, cotinine, 
carbamazepine, triclosan, atenolol, triclocarban, gemfibrozil. The observed concentrations were 
significantly lower than those observed in wastewater effluents.  
5.4 Surface waters 
In the water column, substances may be degraded abiotically via photodegradation and/or 
hydrolysis or biotically by aerobic or anaerobic organisms. Highly sorptive substance may partition to 
the bed sediment. For example, mesocosm studies using ivermectin show that when added to water, 
the compound dissipates quickly from the water column and that this dissipation is observed increase 
in the concentration of the compound in the bed sediment (e.g. Sanderson et al., 2007). A significant 
amount of information is available on the fate and behaviour of many veterinary medicines in water-
sediment systems due to the use of veterinary medicines as aquaculture treatments (Boxall et al., 
2004). For selected new human pharmaceuticals, companies are required to test the fate of the 
compound in a laboratory sediment-water system so an increasing amount of information is becoming 
available for these substances. While many compounds degrade very quickly, others persist in the 
sediment for months to years. 
5.5. Uptake into biota 
ECs may also be taken up from soil into biota (Migliore et al., 2003; Kumar et al., 2005; Boxall 
et al., 2006; Dolliver et al., 2007). The potential uptake of veterinary and human medicines into plants 
is receiving increasing attention. Studies with a range of veterinary medicines (Boxall et al., 2006) 
showed that a number of antibiotics are taken up by plants following exposure to soil at 
environmentally-realistic concentrations of the compounds whereas other compounds were not 
observed to be accumulated. Less work has been done on human pharmaceuticals but recent studies 
have shown that the antidepressant compound fluoxetine be accumulated by brassicas (Redshaw et al., 
2008). The factors affecting uptake of ECs into plants are poorly understood and this is an area that 
needs much more research. Recently, the uptake of ECs into other soil organisms has also been 
explored, for example Kinney et al. (2008) reported the occurrence of anthropogenic waste indicators, 
including the pharmaceutical trimethoprim in earthworm tissue.  
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6. Occurrence of emerging contaminants in soils, surface waters and groundwaters 
The detection of ECs in the environment can be highly challenging as they typically occur in the 
environment at very low levels and, for many ECs, reference standards, which are required to validate 
the analytical methods, are not available. Analysis is also very time consuming and costly and requires 
access to highly sophisticated equipment. Robust methods are however now available for detecting 
many emerging contaminants (e.g. pharmaceuticals, personcal care products, veterinary medicines and 
transformation products) in waters, soils and sediments. While many of these methods cannot yet be 
UHJDUGHGDVµURXWLQH¶ WKH\DUHEHJLQQLQJ WREHXVHGLQQXPHURXV ODERUDWRULHVDURXQGWKHZRUOG)RU
some ECs, such as the engineered nanomaterials, detection in the environment is still not currently 
possible due to a lack of sensitive techniques for detection and characterization of these materials in 
complex matrices (Tiede et al., 2008). The analysis of many nanomaterials in environmental samples 
is further complicated that waters and soils already contain numerous natural nanoparticles ± one of 
the major challenges is how we distinguish between natural and man-made materials. 
Nevertheless, availability of liquid chromatography-mass spectrometry analytical techniques has 
allowed us to study the occurrence and fate of many ECs in environmental systems. The focus of the 
analytical work has been on detection of ECs in surface waters and wastewater effluents (Ternes, 
2001; Heberer, 2002; Benotti et al., 2009) with less work being done on soils, groundwaters and only 
a few studies exploring detection in other biological environmental matrices such as vertebrate, 
invertebrate and plant material (Brooks et al., 2005; Ramirez et al., 2009). The surface water 
monitoring studies tend to look at sites where the ECs are being released from a range of sources, 
including wastewater emissions, it is therefore often difficult to determine whether an EC is of 
agricultural origin or not. 
A few studies have however focused on detection of ECs in agricultural catchments. These 
investigations have detected a range of pharmaceuticals, veterinary medicines, personal care products 
hormones and transformation products across a number of countries in N. America, Asia and Europe 
(Table 2). While concentrations are generally low (i.e. in the ng/l range), many ECs have been 
detected throughout the year.  
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Table 2. Emerging contaminants detected in runoff and drainage waters, surface waters or groundwaters 
associated with agricultural land 
EC class Product class Countries where the EC class has been 
monitored and detected 
Veterinary 
medicines 
Antibiotics Canada, United States, United Kingdom, 
Japan, China, Korea Luxembourg, 
Switzerland, Chinese Taipei 
 Antiparasitic agents United Kingdom, Canada 
 Ionophores Canada, United States, Denmark 
Human medicines Analgesics Canada 
 Antibiotics Switzerland 
 NSAIDs Canada 
 E-blockers Canada 
Human personal 
care products 
Antibacterials Canada, United States 
 Insect repellants United States 
 Polycyclic musks United States 
Hormones Synthetic estrogens United States 
 Natural estrogens United States, Chinese Taipei 
 Androgens United States 
Transformation 
products Transformation products of herbicides 
Greece, United States, France, 
Germany, Switzerland 
 Transformation products of pesticides Canada, United States 
Source: adapted from reviews by Monteiro and Boxall (2010); Boxall et al. (2010). 
7. Effects and risks of emerging contaminants on ecosystems and humans 
A wealth of research is now being done to assess the effects of emerging contaminants on 
ecosystems and human health. The following section explores the effects of a range of emerging 
contaminants. While the examples are not always relevant to the aquatic environment, they do 
illustrate the potential hazards associated with different classes of EC. 
7.1 Human and veterinary medicines 
7.1.1 Acute and chronic effects from standard studies 
In the EU and North America, the environmental risks of human and veterinary medicines now 
need to be assessed before a product can be marketed and in order to perform the risk assessment, data 
are often required on the effects on aquatic and terrestrial organisms (Breton and Boxall, 2003). A 
reasonable body of data is therefore available on the effects of many medicines on aquatic 
invertebrates, fish and algae, earthworms, plants and soil microbes (e.g. see Boxall et al., 2004a). 
These data have generally been obtained using standard acute or chronic ecotoxicity studies. The acute 
studies are short term (2-4 days) with mortality (fish and invertebrates) or growth (algae) as the 
endpoint whereas chronic studies last weeks to months and investigate effects on growth and 
reproduction. Acute effects of pharmaceuticals are observed at concentrations orders of magnitude 
higher than measured concentration and generally algae are more sensitive in these studies (Box 2). 
Chronic effects are seen at concentrations much lower than in the acute studies but. As with the acute 
studies, effects in standard chronic studies are typically seen at concentrations that are much higher 
than measured concentrations, indicating that levels of pharmaceuticals in the natural environment will 
not be high enough to cause these effects. 
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Box 5. Distribution of measured acute and chronic ecotoxicity endpoints for human medicines 
 in standard studies 
GRAPH A ACUTE DATA 
LC50 ± concentration of compound that causes 50% 
mortality in the study 
EC50 ± concentration of compound that causes 50% 
effect (e.g. reduction in growth or reproduction) 
 
GRAPH B CHRONIC DATA 
 
The data were taken from the published literature. The data show that generally, algal species are more sensitive in 
acute studies than fish and daphnia whereas in chronic studies, fish are the most sensitive. The effect concentrations are 
significantly higher than concentrations of pharmaceuticals seen in the environment indicating that pharmaceuticals will not 
be at a high enough level in the environment to elicit the effects that were assessed. 
7.1.2  Non-standard effects 
Pharmaceuticals compounds are either designed to be highly active and interact with receptors in 
humans and animals or they are toxic towards health threatening organisms such as bacteria, fungi and 
parasites. Many lower animals have receptor systems similar to humans and animals moreover many 
of the groups of organisms that affect human and animal health and which are targeted by 
pharmaceuticals play a critical role in the functioning of ecosystems. It is therefore possible that 
pharmaceuticals may cause subtle effects on aquatic and terrestrial organisms that might not be picked 
up in the standard studies discussed above.  
For human medicines in particular, releases to the environment are likely to be almost continuous 
so organisms will be exposed for much longer durations than those used in standard tests. Because of 
this, researchers have begun to investigate some of the more subtle effects caused by long-term low-
level exposure to pharmaceuticals. A wide range of subtle impacts have been reported so far (Table 3) 
including effects on oocytes and testicular maturation; impacts on insect physiology and behaviour; 
effects on dung decomposition; inhibition or stimulation of growth in aquatic plant and algae species; 
and the development of antibacterial resistance in microbes. Whilst, many of these effects have been 
seen at environmentally-realistic concentrations, the significance in terms of environmental health has 
yet to be established ± this will be one of the challenges in the coming years. 
More detail of some of the non-standard impacts of pharmaceuticals is given in the following 
sections. 
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Table 3. Reported non-standard effects of human and veterinary medicines on aquatic and terrestrial 
organisms 
Medicine class Reported effect Reference 
Anorexic treatments Hormonal effect in crabs and crayfish Reported in Daughton and 
Ternes, 1999 
Estrogens Endocrine disrupting effects on fish  
Parasiticides Effects on insect development and physiology; Effect 
on rate of dung decomposition  
Floate et al., (2005); Sommer 
and Bibby (2002) 
Antibacterials Selection of antibacterial resistance;  Impacts on the 
structure of soil microbial communities; Inhibition of 
growth blue-green algae and aquatic plants; 
Biochemical effects in fish 
Sengelov et al., (2003); Pomati 
et al., (2004); Westergaard, et 
al., (2001); Lavelle et al., 
(2004) 
Anti-inflammatory Stimulation of growth of blue green algae and 
inhibition of growth of aquatic plants; Effects on 
structure of fish hepatocytes 
Pomati et al., 2004 
Lipid regulator Biochemical effects in fish Lavelle et al., 2004 
Analgesic Biochemical effects in fish Lavelle et al., 2004 
Beta blocker Biochemical effects in fish Lavelle et al., 2004 
Lipid regulator Biochemical effects in fish Lavelle et al., 2004 
Antianxiety drug Effects on development of invertebrates Pascoe et al., 2003 
Cardiac glycoside Effects on development of invertebrates Pascoe et al., 2003 
Calcium channel blocker Effects on development of invertebrates Pascoe et al., 2003 
Source: Author, see References. 
Avermectins and terrestrial and aquatic invertebrates 
The avermectins are powerful insecticides. Exposure to avermectins can elicit a number of 
responses, including adult and larval mortality, an effect on feeding, disruption of water balance, a 
reduction in growth rate, interference with moulting, inhibition of metamorphosis and/or pupation, 
prevention of adult emergence, disruption of mating and interference with egg production and 
oviposition (Floate et al., 2006). As a consequence, dung from animals treated with avermectins may 
not support the development of either target insects (e.g. Haemotobia irritans, Musca autumnnalis, 
Musca domestica and Musca vetustissimia) or non-target (e.g. sphaerocerids, muscids, sepsids and 
coleopterans) insects (Floate et al., 2006). The toxicity of avermectins to dung insect populations may 
be associated with retardation in the rate of breakdown of pats. For example pats containing 
ivermectin have been shown to be intact after 340 days, whereas, untreated pats were largely degraded 
within 80 days (e.g. Floate, 1998).  
The effects on other invertebrates have not been extensively investigated although investigations 
with worms demonstrated no effect on population density (Floate et al., 2006). The possible indirect 
effects of avermectin contaminated dung on vertebrate populations (e.g. bats and birds) have also been 
highlighted (e.g. Floate et al., 2006). Their use may result in depletion in the quantity and quality of 
vertebrate food resources, this may be particularly critical during the breeding season or when young 
animals are foraging and fending for themselves. 
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Hormones and aquatic wildlife 
Livestock waste manure may be a significant source of hormones, including steroid estrogens 
such as estradiol, estrone and estriol (Hanselman et al., 2003). It is known that very low concentrations 
(10 ± 100 ng/l) of these compounds can cause significant effects on the reproductive biology of fish 
and amphibians (Oberdorster et al., 2001; Tyler et al., 1998). For example estrone has been shown to 
induce the egg yolk protein vitellogenin in male fish and to affect testicular growth at 30 ng/l (Panter 
et al., 1998; 2000). 
Antibiotics and soil microbes 
Several studies have investigated the effects of antimicrobial substances on microbes in soils and 
sediment (e.g. Westergaard et al., 2001). Selected substances have been shown to inhibit soil bacteria 
as well as reducing the hyphe length of active moulds. Effects on the microbial composition of soils 
have also been demonstrated (e.g. Sommer and Bibby, 2002). With the exception of a few studies 
(e.g. Sommer and Bibby, 2002), effects on soil and sediment functioning have not been considered. 
Those studies that have been performed demonstrate that veterinary antibacterials may affect sulfate 
reduction in soil and that they inhibit the decomposition of dung organic matter in soil (e.g. Sommer 
and Bibby, 2005). A few studies have also investigated the potential for antibiotics that are excreted by 
animals to select for antibiotic resistance. For example, Heuer and Schmalla (2007) investigated the 
effects of pig manure and sulfadiazine on bacterial communities in soil microcosms using two soil 
types. In both soils, manure and sulfadiazine positively affected the quotients of total and sulfadiazine-
resistant culturable bacteria. The results suggest that manure from treated pigs enhances spread of 
antibiotic resistances in soil bacterial communities. A few studies have also explored effects of 
veterinary antibiotics on aquatic microbes. Schallenberg and Armstrong (2004) explored the impacts 
of filtered water from an agricultural drain on lake bacteria. They showed that the drainage water 
reduced the abundance of aquatic bacteria in a shallow coastal lake and the data indicated that these 
effects may be due to antibiotics. Finally, in a recent study (Monteiro and Boxall, in press), explored 
the indirect effects of veterinary antibiotics were explored. In this study, the effects of 
sulfamethoxazole on the degradation of a range of human medicines in soil were explored. Data for 
the non-steroidal anti-inflammatory drug, naproxen indicated that the addition of sulfamethoxazole 
significantly reduced the rate of degradation of the human drug. This observation may have serious 
implications for the risks of other compounds that are applied to the soil environment such as 
pesticides. 
Diclofenac and vultures 
The veterinary use of the non-steroidal anti-inflammatory drug diclofenac was found to be 
responsible for the decline in populations of three vulture species in Asia (Oaks et al., 2004). The 
decline in the populations was caused by renal failure and visceral gout which attributed to the 
veterinary use of diclofenac in cattle. The decline in vulture populations, arising from the use of 
diclofenac, is thought to have serious implications for human health. As vultures are a keystone 
species, their population decline has a range of ecological, socio-economic, cultural and human health 
impacts.  
For example, Markandya et al. (2008) reviewed the economic implications of the human health 
impacts of the decline in vulture populations. Livestock carcasses are the main food source for 
vultures but are also eaten by dogs. As that vulture populations have declined, the dog populations 
have increased. As dogs are the main source of rabies in humans in India, it is probable that the 
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incidence o rabies in humans has increased and hence mortality has increased. Markandya et al. (2008) 
estimated that it the vulture decline had likely caused many thousand extra deaths in the human 
population.  
Effects of pharmaceuticals on wildlife may be a broader issue. In a recent study, residues of 
fluoroquinolone antibiotics have been detected in eggs of vultures and red kites in Spain and the 
presence of these residues have been associated with fatal embryo chondral damage (Lemus et al., 
2009). One reason why top predators may be particularly sensitive to the effects of a pharmaceutical is 
that many do not possess the detoxification enzymes which are present in (and which protect) the 
human population.  
7.1.3  Human health effects of human and veterinary medicines 
Humans and top predators may be exposed to pharmaceuticals in the environment by a number of 
routes including the consumption of: 1) plants that have accumulated substances from soils as a result 
of exposure to contaminated sludge, manure, irrigation water and slurry; 2) livestock that have 
accumulated veterinary medicines through the food chain; 3) fish exposed to pharmaceuticals released 
to surface waters either intentionally (aquaculture treatments) or unintentionally; 4) abstracted 
groundwater and surface waters containing residues of pharmaceuticals that is then used for drinking 
water; and 5) for top predators, contaminated food sources such as insects and other invertebrates and 
other wildlife species. Exposure may also occur via the inhalation of dust emitted from intensively 
reared livestock facilities (Hamscher et al., 2001). 
While, measured and predicted concentrations of pharmaceuticals in drinking water, crops and 
fish are likely to result in exposure levels that are well below human Therapeutic Dose Levels or 
Acceptable Daily Intakes (ADIs) (e.g. Cunningham et al., 2009; Webb et al., 2003; Boxall et al., 
2006; Watts et al., 2007; Brooks et al., 2005; Ramirez et al., 2009; Hughes et al., 2006; Schwab et al., 
2005; Hughes et al., 2006), there is concern from the scientific and regulatory communities and the 
general public that exposure to pharmaceuticals in the environment may be affecting human health. 
These concerns arise from the fact that: 
The exposure, even though at low levels, is likely to be long-term: 
x Individual pharmaceuticals do not occur in drinking water on their own but occur as a 
mixture, which introduces the possibility of synergistic or additive interactions or 
environmental contraindications between an environmental residue and a medicine taken by 
a patient for an existing condition; 
x Humans will be exposed to pharmaceuticals via a number of routes, whereas, most risk-
assessment studies have only considered one route of exposure; 
x Degradation processes, particularly in drinking water treatment processes, may result in 
transformation products that may be of greater health concern than the parent compound. For 
example, some pharmaceuticals with amine functionality are possible precursors for 
nitrosamines ± which can be mutagenic and carcinogenic (Krasner, 2009). 
x Some compounds, e.g. selected cytotoxic compounds, are known to be extremely potent so it 
has been recognised that environmental exposure to these should receive special attention 
(Rowney et al., 2009). 
x Indirect effects of residues in the environment, such as the selection of antibiotic resistant 
micro-organisms, cannot currently be ruled out (Witte et al., 1998; Boxall et al., 2003; Heuer 
and Schmalla, 2007; Byrne-Bailey et al., 2009) 
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There is therefore a need to better understand the potential implications of residues of human and 
veterinary medicines in the environment on the health of humans and other top predators so that 
pharmaceuticals can be used in a sustainable way and so that public confidence in the safety of food 
and drinking water can be maintained. It is important to recognise that pharmaceuticals (particularly 
human medicines) are the most extensively studied group of compounds in terms of human toxicology 
so much of the data needed to determine risks to humans and other top predators already exist 
(e.g. data from rat and dog studies on fluoroquinolones show similar effects as seen in vultures and red 
kites in the wild (Lemus et al., 2009) and, if the exposure pathway had been anticipated, the impacts of 
diclofenac could have been predictable based on adverse response data for the drug). 
7.2 Engineered nanomaterials 
While data are not yet available on the environmental effects of nanopesticides, data are 
becoming increasingly available on many of the engineered nanomaterials that might be released to 
the agricultural environment associated with sewage sludge (such as nanosilver, titanium dioxide and 
fullerenes). Studies have explored the uptake and effects of nanomaterials on a range of environmental 
species and endpoints (Oberdorster, 2004; Lovern and Klaper, 2006; Oberdorster et al., 2006; 
Kashiwada, 2006). In the laboratory, aquatic organisms appear to rapidly accumulate selected 
nanomaterials, including carbon black, titanium dioxide and polystyrene (e.g. Lubick, 2006; Stone et 
al., 2006).  
Laboratory studies with microbes have reported effects of fullerenes on microbial physiology 
(e.g. Fortner et al., 2005, Fang et al., 2007) whilst silver nanoparticles have been shown to accumulate 
in bacterial membranes, ultimately causing cell death (Sondi and Salopek-Sondi, 2004). In some cases 
there is however a mismatch between laboratory studies and studies to assess impacts in the real 
environment. For example, under realistic exposure conditions, fullerenes have little impact on the 
structure and function of the soil microbial communities and microbial processes (Tong et al., 2007).  
The available data indicate that nanomaterials have low acute toxicity to aquatic organisms 
(e.g. Lovern and Klaper, 2006; Oberdorster et al., 2006; Zhu et al, 2006) although they may cause 
oxidative stress and affect the physiology and reproduction (Lovern and Klaper, 2006; Oberdorster et 
al., 2006; Templeton et al., 2006). Studies with algae have demonstrated that titanium dioxide 
nanoparticles inhibit algal photosynthesis (Kim and Lee, 2005). Studies with fish have demonstrated 
oxidative stress in the brains of fish exposed to fullerenes at very low concentrations (Oberdorster, 
2004). Although there is some debate over whether the effects were caused by the fullerenes or the 
carrier solvent. Studies with plants have shown alumina nanoparticles loaded with phenanthrene to 
inhibit plant growth (Yang and Watts, 2005).  
The factors and processes affecting ecotoxicity seem to be complex. The impacts of 
nanomaterials on environmental organisms seems to be determined by a range of characteristics 
including dissolution potential, aggregation potential, particle surface properties and the characteristics 
of the exposure environment and the biochemical, physiological and behavioural traits of the organism 
of interest (e.g. Dhawan et al., 2006, Rogers et al., 2007). In the future, therefore we need to bring the 
exposure and effects studies closer together in order to determine whether nanomaterials can pose a 
risk to the environment (Tiede et al., 2008; SCENIHR, 2007). 
7.3 Transformation products 
Data have been generated on the ecotoxicity of pesticide, veterinary medicine and biocide 
degradates because of the requirement of regulatory schemes (e.g. the EU pesticide directive 
91/414/EEC requires that all major degradates formed at >10% of the applied parent compound are 
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evaluated). Generally, these studies have determined acute effects on organisms used in standard 
toxicity tests (e.g. daphnids, rainbow trout, earthworms) ± the reason being that for the vast majority of 
pesticide metabolites, the acute package demonstrates no risks, so no further testing is triggered. A few 
studies have however assessed sublethal and longer term effects (e.g. Osano et al., 2002a and b). The 
impacts (both acute and longer-term) of a few industrial substances have also been investigated, most 
notably degradates of the non-ionic surfactants (nonylphenol mono- and diethoxylates, nonylphenol 
carboxylates, nonylphenol ethoxycarboxylates and nonylphenol itself). These substances are believed 
to have oestrogenic activity due to their ability to mimic the endogenous hormone 17E-estradiol 
(Jobling et al., 1996). 
The available data demonstrate that in most cases degradates have similar toxicity to or are less 
toxic than their parents (Grasso et al., 2002, Sinclair and Boxall, 2003). However there are instances 
where degradates can be more toxic (Box 3). For example, of the degradates investigated by Sinclair 
and Boxall (2003), 41% were less toxic than their parent, 39% had a similar toxicity to their parent (to 
account for interlaboratory differences it was assumed that EC50 values within a factor of 3 indicate 
similar toxicity), 20% of degradates were more than three times more toxic and some degradates (9%) 
were more than an order of magnitude more toxic. In general, increases in toxicity from parent to 
degradate were observed for parent compounds that had a low toxicity. 
7.4 Mixtures 
It is important to recognise that the environment will not be exposed to single ECs but will be 
exposed to a mixture of ECs and other contaminants. There is strong evidence from the literature that 
compounds with a similar mode of action work together to create effects greater than caused by each 
component of the mixture applied singularly (Kortenkamp et al., 2009). Fewer data are available on 
the ecotoxicity of mixtures of compounds with dissimilar mode of action but where the data are 
available, they indicate that these mixtures also cause effects greater than seen for the single 
substances. It is therefore important that combination effects of ECs and ECs and other contaminants 
are considered in the future. 
Modelling approaches are available for estimating the combined effects of chemicals, namely the 
Concentration Addition model and the Independent Action model. Through laboratory-based studies, 
these models have been shown to provide reasonable estimations of combination effects (Kortenkamp 
et al,WPD\EHSRVVLEOHWRXVHWKHVHPRGHOVLQWKHULVNDVVHVVPHQWRI(&¶V 
ECs may also affect organisms indirectly through interactions. For example there is concern that 
nanomaterials can act as carriers for other contaminants into aquatic organisms. This interactive effect 
was observed in combination studies with fullerene nanoparticles and polycyclic aromatic 
hydrocarbons. In these studies, the presence of fullerenes increased the rate and extent of uptake of 
phenanthrene in daphnids. Studies have also shown that the presence of antibiotics in the environment 
may affect the persistence of other contaminants (Monteiro and Boxall, 2009). 
The issue of mixture interactions is not specific to ECs but is a general problem that is relevant to 
all contaminants in the natural environment. 
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Box 6.  Comparison of effects data for parent compounds and their associated  
transformation products 
The graph shows the relationship between the ecotoxicity (to fish, daphnids and algae) of parent compounds 
and their transformation products. All of the points that fall above the solid line (x=y) correspond to transformation 
products that are less toxic than their parent compound. Points below the line correspond to transformation products 
that are more toxic than the parent, those below the line x=y/10 are more than 10 x more toxic and those below the 
line x=y/100 are more than 100 x more toxic. 
There are a number of possible explanations for these toxicity increases: 1) The active moiety of the parent 
compound is still present in the transformation product (black diamonds); 2) The transformation product is the active 
component of a pro-compound (white diamonds); 3) The bioconcentration factor for the transformation product is 
greater than the parent (black and white triangles); and 4) the transformation pathway results in a compound with a 
different and more potent mode of action than the parent (white squares) (Sinclair and Boxall, 2003).   
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8. Regulations and policy instruments 
The environmental impacts of a number of classes of ECs are captured by existing regulations 
and policy instruments. These are described below. 
8.1 Veterinary medicines 
Manufacturers of veterinary medicines are required to demonstrate the quality, safety, and 
efficacy of a new product before it can be marketed. In the United States the regulatory authority is the 
U.S. Food and Drug Administration. The equivalent authority in the European Union is the European 
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Medicines Evaluation Agency (EMEA) for Europe-wide authorization or Member State regulatory 
authorities if individual country authorization is sought. In Canada the competent authority is Health 
Canada, and in Australia it is the Australian Pesticides and Veterinary Medicines Authority. 
Historically, individual authorities have had their own guidelines for assessing the risks of a 
veterinary product. The Veterinary International Co-operation on Harmonisation (VICH) was 
officially launched in April 1996 to harmonize technical requirements for veterinary product 
registration across the United States, Canada, Australia, Japan, and Europe. Its members include 
representatives from government agencies and industry. VICH currently has working groups drafting 
recommendations in a number of areas including ecotoxicity, safety, efficacy, and pharmacovigilance. 
The ecotoxicity working group has developed a two-phase approach for use in the registration process.  
In the Phase 1 assessment (VICH, 2000) the potential for environmental exposure is assessed on 
the basis of the intended use of the product. Generally, it is assumed that products with limited use and 
limited exposure have limited effects and for these products assessment stops at Phase 1 (i.e., they do 
not require a Phase 2 assessment). The exceptions to this are products for which there are specific 
concerns over activity and use. These automatically require a Phase 2 assessment regardless of the 
potential extent of exposure.  
In Phase 2, a two-tiered approach is used to assess the environmental risks of products that 
identified in Phase I as being of potential risk to the environment (VICH, 2006). Tier A makes use of 
less expensive ecotoxicity and fate studies to make a conservative assessment of risk in the 
environmental compartment of interest. If a product cannot be shown to pose an acceptable risk using 
these data, then the risk assessment is refined in Tier B. 
8.2 Human medicines 
In the EU and the US, guidelines are also available for the environmental risk assessment of 
human pharmaceuticals. The current guidance document, adopted by the EMEA Committee for 
Human Medicinal Products, came into effect in the end of 2006. An Environmental Risk Assessment 
(ERA) is required for all new marketing authorisation applications for medicinal products, for type II 
variations (major changes to the marketing authorisation) and for extension applications if there is an 
increase in environmental exposure. The ERA is performed in 2 phases. In Phase I, the concentration 
of the drug in the aquatic environment is calculated. If the PEC is below 10 ng/l, then it is assumed 
that the substance will pose a low risk to the environment, unless it is a substance the effects 
reproduction of vertebrates or lower animals. If the PEC is above 10 ng/l, then a Phase 2 assessment is 
required. Phase 2 is a two phase process and in phase 1 the fate and effects (i.e. algal growth study, 
Daphnia reproduction study, and fish early life stage study) of the compound in the aquatic 
environment are assessed. In tier B, extended effects analysis studies may be performed and if the Koc 
of the compound is > 10,000 then risks to the terrestrial environment, arising from sludge application 
to land, also need to be considered. Unlike veterinary medicines, a marketing authorisation for a 
human pharmaceutical will not be refused based on the ERA. 
8.3 Transformation products  
The environmental risks of transformation products have to be considered for many classes of 
chemicals. For example, the pesticides directive (2009/1107) requires assessment of major 
transformation products and relevant transformation products of plant protection products. Similar 
requirements also exist for transformation products of pesticides in other geographical locations 
(e.g. FIFRA in the USA), biocides and human and veterinary medicines. 
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8.4 Nanomaterials 
As engineered nanomaterials are expected to be used in a wide range of product types, it is likely 
that a range of environmental regulatory frameworks will apply to them. For example, industrial uses 
are likely to be covered by the Registration, Evaluation, Authorization and Restriction of Chemicals 
(REACH) regulations, whereas applications in the pharmaceutical, biocides, veterinary medicines and 
plant protection products will be covered by other specific frameworks (e.g. Aitken et al., 2006).  
8.5 Other regulatory frameworks 
Many ECs, that are not covered by the mechanisms described above, are likely to be covered by 
the recent EU Regulation (EC) No. 1907/2006, the REACH Regulations, which entered into force on 
June 1, 2007. REACH will require an environmental safety assessment of all chemicals used or 
imported into the EU in quantities exceeding one tonne. The Water Framework Directive and the new 
European soils policy may also influence the management of ECs in the natural environment. 
9. Risk mitigation 
In the event that an EC is identified as posing an unacceptable risk to the environment, there are a 
number of options that exist for managing or mitigating the risks. For example, over recent years there 
has been a steadily increasing drive within the pharmaceutical industry towards the synthesis of 
µJUHHQHU¶SKDUPDFHXWLFDOVDQGWKHDGRSWLRQRIJUHHQFKHPLVWU\PHWKRGVDQGWHFKQRORJLHV&ODUNet al., 
2008). The majority of improvements have been made to the manufacturing process, although 
increasing emphasis is being placed on the development of approaches for minimising impacts during 
use including the development of more efficient wastewater treatment technologies, and development 
of pharmaceuticals that are benign by design or designed for biodegradability (Clark et al., 2008). The 
implementation of tax and other incentives could make these eco-pharmacostewardship approaches 
more attractive to pharmaceutical companies and hence increase their uptake. 
Classification and labelling approaches may also help to minimise risks. A good example of such 
a scheme is a system running in Sweden which is a voluntary scheme that targets active 
pharmaceutical substances where information on their environmental impacts is made publicly 
available on websites and in information booklet (Stockholms Läns landsting, 2006). The extension of 
a model similar to the Swedish scheme could potentially be desirable on a European level. Key issues 
for developing and implementing classification & labelling schemes include the standardisation of the 
information used, the criteria applied, who provides the information and mode of communication 
(Clark et al., 2008). 
In Europe, drug take back schemes of unused/expired medication are an obligatory post-
pharmacy stewardship approach that reduces the discharge of pharmaceuticals into environmental 
waters and minimises the amounts of pharmaceuticals entering landfill sites. Although the contribution 
of improper disposal of pharmaceuticals to the overall environmental burden is generally believed to 
be minor (Daughton and Ruhoy, 2009), drug take back schemes are still considered to be important. 
High levels of public awareness and education on the environmental consequences of the disposal of 
unused/expired drugs are key for the success of such schemes.  
Changes in agricultural practices may also minimise the risks of ECs to the environment. A range 
of approaches can be used including changes in treatment timings and intensities, changes in 
manure/sludge application rates and timings, development of recommendations on when not to apply 
manure and biosolids (e.g. where slopes are unsuitable), and specification of buffer zones can protect 
water bodies (Pope et al., 2009). For example, injection application has been shown to reduce 
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overland runoff of pharmaceuticals and personal care products when compared to a broadcast 
application (Topp et al., 2008). The timing of application might also minimize the risk of 
contamination. For example, the application of sewage sludge during dry periods would minimise the 
potential for some substances to be transported to surface waters.  
10. Environmental risks of ECs in the future 
It is also important to recognize new contaminants will emerge in the future due to a range of 
drivers including: demographic change; changes in land use; changes in waste disposal practices 
(e.g. moving to composting and anaerobic digestion approaches with subsequent application of the 
compost, digestate etc. to land); and global climate change. A recent study (Boxall et al., 2009) 
explored the potential impacts of climate change on the risks of contaminants in agricultural systems, 
focusing on the UK environment. The study concluded that climate change is likely to impact the 
dispersion of chemicals in the environment (Figure 4). In addition changes in climate are likely to 
affect the amounts and types of chemical used for in agriculture. Future risks of chemicals could 
therefore be very different than today so it is important that we begin to assess the implications of 
climate change for changes in environmental and human exposures to chemicals and the subsequent 
impacts in the near term and in the future. Based on the work, overall it is anticipated that climate 
change will result in an increase in risks of chemicals from agriculture to environmental and human 
health. The magnitude of the increases will be highly dependent on the contaminant type. Climate 
change will fuel increased use of pesticides and biocides as farming practices intensify. Extreme 
weather events will mobilise contaminants from soils and faecal matter, potentially increasing their 
bioavailability. Climate change will also affect the fate and transport of chemical contaminants in 
agricultural systems. Increases in temperature and changes in moisture content are likely to reduce the 
persistence of chemicals while changes in hydrological characteristics are likely to increase the 
potential for contaminants to be transported to water supplies. Risks of many particulate and particle-
associate contaminants could therefore increase significantly. The study concluded that it should be 
possible to manage many of these risk increases through better regulation, monitoring and the 
development of long-term research programmes.  
11. How can policy makers identify emerging contaminants of most concern? 
It is clear from the above that a wide range of ECs will be released to the environment and that 
the nature of the ECs released to the environment will vary both temporally and spatially. We 
probably do not have the resources to experimentally assess the risks of every potential EC and there 
is therefore an urgent need for approaches that can be applied by environmental agencies and/or policy 
makers within a particular region to identify ECs of most concern. These ECs would then be the focus 
of monitoring investigations and fate and effects studies. Over the past few years there has been 
increasing interest in the development of prioritization approaches for identifying ECs of most 
concern. In this Section a number of these approaches that have been used for agricultural ECs are 
described. 
A number of previous studies have been performed to identify priority emerging environmental 
pollutants (e.g. Boxall et al., 2003; Thomas et al., 2004; Capelton et al., 2006; Sinclair et al., 2006; 
Sanderson et al., 2003; Table 3). These have considered a range of classes (veterinary and human 
medicines and degradates), different exposure pathways and have been aimed at different protection 
goals (selected priority lists of relevance to agricultural systems are given in Appendix A). 
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Figure 4. Predicted impacts of climate change on transport processes for contaminants  in agricultural 
systems 
 
 
 
 
 
 
 
 
 
 
 
 
 
The size of the arrow indicates the magnitude of change in the transport pathway. The letters indicate the types of contaminant 
that will be transported by the pathway (P = particles, PA = particle associated; S = soluble; V = volatile). The size of the letter 
indicates that importance of the pathway for that contaminant type. 
Source: Taken from Boxall et al. (2009). 
 
Table 4. Previous horizon scanning studies for emerging environmental contaminants 
Study Emerging 
contaminant class Protection goal Exposure pathways Parameters 
Boxall et al., 2003 Veterinary medicines Environmental Soil, Surface water Usage, Ecotoxicity 
Thomas et al., 2004 Human medicines Environmental Surface water Usage, Ecotoxicity, 
Therapeutic dose 
Capelton et al., 2006 Veterinary medicines Human Drinking water, 
Vegetables, Meat, Fish 
Usage, Toxicity 
Sinclair et al., 2006 Transformation 
products 
Human Drinking water Usage, Sorption, 
Persistence, Toxicity 
Sanderson et al., 
2003 
Human medicines Environmental  Usage, Exposure, 
Ecotoxicity 
Eljarrat and Barcelo, 
2003 
Emerging persistent 
organic pollutants 
(e.g. dioxin-like 
compounds) 
Human Sediments, sludge Chemical analysis, 
toxicity 
Matrix
flow
S
Drainflow
P/PA
Runoff and 
Flooding
P/PA
S
Spray drift 
PA/S/V
Dust 
transport
P/PA
Plant
uptake 
S
Volatilisation
V
Minimal
change
Moderate
increase
Large
increase
Vector 
transmission 
P
P = particulate; PA = particle-associated; S = soluble; V = volatile
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Most of these approaches integrate data on the potential hazard of an EC to either organisms in 
the environment or to human health and combine this with estimates of exposure. As no experimental 
data are available on the ecotoxicity and environmental properties of most ECs, the prioritization 
approaches that have been used are very reliant on modelling predictions of fate and effects data. As 
stated in Section 4, many of the modelling approaches that are available for estimating fate properties 
and exposure are not necessarily appropriate for many classes of ECs so the priority lists should be 
viewed with some caution. By developing new or improved models for assessing the fate and effects 
of ECs and integrating these into prioritisation schemes, it should be possible in the future to identify 
ECs of most concern and to focus testing requirements. The prioritisation approaches have also 
focused on single compounds and interactions of ECs have not been considered. 
12. Knowledge gaps and research needs 
From the previous sections, it is clear that over the last few years that there has been increasing 
interest in the risks of emerging contaminants in the environment and there are also examples where 
ECs have caused catastrophic impacts on ecosystems (e.g. the effects of diclofenac and vultures). It is 
therefore critical that we continue to work to identify ECs of most concern in a logical and pragmatic 
manner. In order to do this, there are many questions that need to be addressed:  
x What are the risks of substances that have yet to be studied? ± Due to resource limitations 
only a small proportion of substances in use today have been investigated. There is therefore 
a need to develop an understanding of how other substances will affect the environment and 
for the further development of approaches for identifying substances of most concern. 
x How can we analyse certain emerging contaminants in environmental media? ± While there 
have been significant advances in analytical technology over the last decade which now 
allows us to detect many classes of emerging contaminants at low levels in complex media, 
for selected contaminants (e.g. engineered nanomaterials), method development is still in its 
infancy (e.g. Tiede et al., 2008). 
x Are we considering all the main exposure pathways? ± Current regulatory environmental risk 
assessment approaches for assessing exposure to ECs focus on leaching to groundwater and 
runoff to surface waters from soils. It is possible that important exposure pathways are being 
missed and it is also likely that different exposure pathways will vary in importance from 
one geographical location to another. There is a real need to identify all the potential 
pathways of exposure of environmental organisms to ECs that occur across the globe and, 
where appropriate, to develop models to cope with additional pathways. 
x How can we better assess ecotoxicity? It is possible that current standard ecotoxicity tests 
may not always catch the impacts of selected emerging contaminants (e.g. pharmaceutical 
effects on birds). The use of more subtle endpoints such as impacts on behaviour, physiology 
and biochemistry PLJKWKHOSDVFRXOGµUHDGDFURVV¶DSSURDFKHVIURPPDPPDOLDQWR[LFRORJ\
and pharmacology studies to environmental organisms.  
x How will ECs interact with a) each other; and b) other contaminants? ± The environment 
will be exposed to a mixture of ECs and other contaminants. The combined effects of these 
mixtures are likely to be greater than the single compounds alone. It is important that we 
begin to understand how ECs interact with each other and with other contaminant classes 
and that methods are developed for identifying the implications of these interactions in terms 
of risk to the environment. These studies should not only focus on toxicant-toxicant 
interactions but also interactions which have an indirect impact on risk. 
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x What do the ecotoxicity data mean? ± A number of subtle effects have been demonstrated 
following exposure to selected emerging contaminants at environmentally realistic 
concentrations. We need to establish what these data mean, if anything, in terms of effects on 
ecosystem functioning. 
x What are the mechanisms determining and fate and behaviour of emerging contaminants? ± 
For many traditional contaminants, our understanding of those factors and processes 
affecting fate and behaviour in the environment is well developed and models are available 
for predicting a range of important fate parameters (e.g. sorption, bioaccumulation). 
However, for many emerging chemical contaminant classes, other fate mechanisms appear to 
be important. In the future we need to try and further understand these mechanisms in order 
to develop improved models for use in environmental risk assessment. Additionally we need 
to better understand the effects of manure, sludge and waste matrices on contaminant 
behaviour in agricultural systems. 
x How can we mitigate against any identified risks? ± In the event that a risk of an emerging 
contaminant to the environment is identified, it may be necessary to introduce treatment and 
mitigation options. By better understanding those factors controlling the fate and behaviour 
or different classes of emerging contaminant, we should be better placed to optimise existing 
remediation technologies or develop new approaches to reduce risks. 
x What will agricultural systems look like in the future and how will this effect contaminant 
risk? ± Agricultural systems are likely to look very different in the future due to land use, 
demographic and climate change. These changes are likely to affect the risks of 
contaminants in agricultural systems. It is therefore important that we begin to assess how 
agricultural systems might change in the future and to assess how these changes will affect 
contaminant inputs, exposure, effects and risks.  
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APPENDIX A ± PRIORITY LISTS FOR EMERGING CONTAMINANTS  
IN AGRICULTURAL SYSTEMS 
 
Table A1. High priority veterinary medicines in terms of potential risk to UK ecosystems 
Compound Treatment scenario(s) that pose a 
 µKLJKULVN¶ 
amoxicillin herd and aquaculture 
apramycin herd 
chlortetracycline herd 
cypermethrin herd 
diazinon herd  
dihydrostreptomycin herd 
oxytetracycline herd and aquaculture 
sarafloxacin aquaculture 
sulfadiazine aquaculture 
tetracycline herd 
tylosin herd 
Source: Taken from Boxall  et al. (2003b). 
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Table A2. Priority veterinary medicine active ingredients recommended for further study to assess toxicological risks resulting from human exposure 
pathways 
Veterinary medicine 
active ingredient 
CAS number Therapeutic indication Chemical group Potential to 
reach the 
environment 
Usage Toxicological 
hazard 
Overall 
priority Level 
for detailed 
risk 
assessment 
Albendazolea 54965-21-8 Anthelmintic Benzimidazole Unknown Mediumb High High 
Amoxicillina 26787-78-0 Antimicrobial ȕ-lactam High High High High 
Baquiloprima 102280-35-3 Antimicrobial Diaminopyrimidine derivative 
Unknown High High High 
Chlorhexidinea 55-56-1 Antimicrobial and 
antiseptic 
- High Lowb High High 
Levamisolea 14769-73-4 Anthelmintic Imidazothiazole High Mediumb High High 
Monensina 17090-79-8 Coccidiostat MFA - Unknown Highb High High 
Nitroxynila 1689-89-0 Flukicide - Unknown Mediumb High High 
Oxolinic acid 14698-29-4 Antibiotic MFA Quinolone High Mediumb High High 
Procaine 
benzylpenicillina, c 
6130-64-9 Antimicrobial ȕ-lactam Unknown High High High 
Salinomycin sodiuma 53003-10-4 Coccidiostat MFA - Unknown Highb High High 
Sulfadiazinea 68-35-7 Antibiotic MFA and 
antimicrobial 
Sulfonamide High High High High 
Toltrazurila 69004-03-1 Coccidiocide Triazinetrione derivative High Lowb High High 
Trimethoprima 738-70-5 Antibiotic MFA and 
antimicrobial 
- High High High High 
Altrenogesta 850-52-2 Sex hormone - Unknown Low High Medium 
Bronopola 52-51-7 Antimicrobial - High Unknown Medium Medium 
Chlortetracyclinea 57-62-5 Antibiotic MFA and 
antimicrobial 
Tetracycline High High Medium Medium 
Clavulanic acida 58001-44-8 Antimicrobial - Unknown High Medium Medium 
Deltamethrina 52918-63-5 Ectoparasiticide Pyrethroid ester High Unknown Medium Medium 
(continued) 
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Table A2. (continued) Priority veterinary medicine active ingredients recommended for further study to assess toxicological risks 
 resulting from human exposure pathways 
Veterinary medicine 
active ingredient 
CAS number Therapeutic indication Chemical group Potential to 
reach the 
environment 
Usage Toxicological 
hazard 
Overall 
priority Level 
for detailed 
risk 
assessment 
Diazinona 333-41-5 Ectoparasiticide Organothiophosphate High High Medium Medium 
Dihydrostreptomycina 128-46-1 Antimicrobial Aminoglycoside High High Medium Medium 
Emamectin benzoatea 137512-74-4 Ectoparasiticide Avermectin High Unknown Medium Medium 
Florfenicola 73231-34-2 Antibiotic MFA and 
antimicrobial 
- High Mediumb Medium Medium 
Flumethrin 69770-45-2 Ectoparasiticide Pyrethroid ester High Medium High Medium 
Mebendazolea 31431-39-7 Anthelmintic Benzimidazole Unknown Mediumb Medium Medium 
Medroxyprogesteronea 520-85-4 Sex hormone - Unknown Low High Medium 
Oxytetracyclinea 79-57-2 Antibiotic MFA and 
antimicrobial 
Tetracycline High High Medium Medium 
Procaine hydrochloride 59-46-1 Neurological preparation Amino ester Unknown Mediumb Medium Medium 
Sarafloxacin 98105-99-8 Antibiotic MFA Fluoroquinolone High Low High Medium 
Tetracyclinea 60-54-8 Antimicrobial Tetracycline High High Medium Medium 
Tylosina 1401-69-0 Antibiotic MFA and 
antimicrobial 
Macrolide High High Medium Medium 
Source: Taken from Capleton et al. (2006) 
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